Assessment of Dyspnea in Patients with Chronic Obstructive Lung Diseases with Modified Borg Scale; Descriptive Cross-Sectional Study

Assessment of Dyspnea in Chronic Obstructive Lung Diseases

Authors

  • Azka Mehmood Physiotherapy Department, Lahore College of Physical Therapy, Lahore, Pakistan
  • Roohi Abbas Physiotherapy Department, Lahore College for Women University, Lahore, Pakistan
  • Arslan Saeed Physiotherapy Department, Johar Institute of Professional Studies, Lahore, Pakistan
  • Shamaila Saleem Physiotherapy Department, Sahara Medical College, Narowal, Pakistan
  • Shabana Nawaz Rashid LatifInstitute of Allied Health Sciences, Rashid Latif Khan University, Lahore, Pakistan
  • Saiqa Tabassum Physiotherapy Department, Ibadat International University, Islamabad, Pakistan

DOI:

https://doi.org/10.55735/hjprs.v4i3.243

Keywords:

assessment, chronic obstructive lung disease, dyspnea, modified Borg scale

Abstract

Background: Chronic obstructive lung disease has been defined as the limitation of the bronchial airway that is not frequently fully recovered. It includes emphysema, chronic bronchitis and sometimes asthma. Because of the obstruction in the airway, the patient comes with the presenting complaints of dyspnea, cough, sputum weight loss and cyanosis with variation in the diameter of the wall of the chest. Objective: To subjectively rate dyspnea in patients with chronic obstructive lung disease considering the adult population. Methods: Our current study is a descriptive cross-sectional study. Data for the study was collected from Ghurki Trust Teaching Hospital and Sheikh Zayed Hospital, Lahore, Pakistan. The sampling technique employed is the non-probability sampling technique. The sample size for this study was calculated to be 89 by employing World Health Organization software. Older adult males and females with chronic obstructive lung diseases with presenting complaints of dyspnea were recruited in our study. A modified Borg scale was employed to assess the severity of dyspnea among these patients. The patients were scored for their severity from 0.5 to 10 which is followed by no breathlessness to maximal breathlessness. Written consent forms in Urdu and English were given to all the participants before the conduct of the study. The variables of this study were represented in the form of descriptive statistics, tables, graphs and percentages. Results: Most of the patients with chronic obstructive lung diseases reported suffering from very severe dyspnea. Results showed that 32.6% of patients reported suffering from dyspnea of very severe intensity followed by slight and moderate intensity. Conclusion: Our current study concludes that patients with lung diseases are found to suffer from severe dyspnea and this is one of their major complaints. The modified Borg Scale was found to be very easy to comprehend and was easily implemented in the clinical setups. It gives us a more accurate and reliable rating for the severity of dyspnea in these diseases.

References

Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The lancet 2018; 392(10159): 1736-88. DOI:https://doi.org/10.1016/S0140-6736(18)32203-7

Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American journal of respiratory and critical care medicine 2012; 185(4): 435-52. https://doi.org/10.1164/rccm.201111-2042ST

Gruenberger J-B, Vietri J, Keininger DL, Mahler DA. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. International journal of chronic obstructive pulmonary disease 2017: 937-44. https://doi.org/10.2147/COPD.S123744

Zhang H, Hu D, Xu Y, Wu L, Lou L. Effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Annals of medicine 2022; 54(1): 262-73. https://doi.org/10.1080/07853890.2021.1999494

O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Advances in therapy 2020; 37: 41-60. https://doi.org/10.1007/s12325-019-01128-9

Fukushi I, Pokorski M, Okada Y. Mechanisms underlying the sensation of dyspnea. Respiratory Investigation 2021; 59(1): 66-80. https://doi.org/10.1016/j.resinv.2020.10.007

Binks AP. Dyspnea. Handbook of Clinical Neurology 2022; 188: 309-38. https://doi.org/10.1515/mr-2024-0006

Simon ST, Bausewein C, Schildmann E, et al. Episodic breathlessness in patients with advanced disease: a systematic review. Journal of pain and symptom management 2013; 45(3): 561-78. https://doi.org/10.1016/j.jpainsymman.2012.02.022

Simon ST, Weingärtner V, Higginson IJ, Voltz R, Bausewein C. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi survey. Journal of pain and symptom management 2014; 47(5): 828-38. https://doi.org/10.1016/j.jpainsymman.2013.06.013

Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Academic emergency medicine 2001; 8(12): 1153-7. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1553-2712.2001.tb01132.x

Johnson MJ, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. European Respiratory Journal 2016; 47(6): 1861-4. DOI: 10.1183/13993003.02089-2015

Stevens JP, Dechen T, Schwartzstein R, et al. Prevalence of dyspnea among hospitalized patients at the time of admission. Journal of pain and symptom management 2018; 56(1): 15-22. e2. https://doi.org/10.1016/j.jpainsymman.2018.02.013

Reychler G, Beaumont M, Latiers A-C, Pieters T, Fremault A. Dyspnea could be accurately assessed by a caregiver in hospitalized patients with respiratory diseases: Interrater reliability and agreement study. Brazilian journal of physical therapy 2021; 25(6): 735-40. https://doi.org/10.1016/j.bjpt.2021.04.010

Williams MT, Lewthwaite H, Paquet C, et al. Dyspnoea-12 and multidimensional dyspnea profile: systematic review of use and properties. Journal of Pain and Symptom Management 2022; 63(1): e75-e87. https://doi.org/10.1016/j.jpainsymman.2021.06.023

Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Supportive care in cancer 2006; 14: 444-53. https://doi.org/10.1007/s00520-005-0009-2

Zhuang Q, Yang GM, Neo SH-S, Cheung YB. Validity, reliability, and diagnostic accuracy of the Respiratory Distress Observation Scale for assessment of dyspnea in adult palliative care patients. Journal of Pain and Symptom Management 2019; 57(2): 304-10. https://doi.org/10.1016/j.jpainsymman.2018.10.506

Kondziella D, Bender A, Diserens K, et al. European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness. European journal of neurology 2020; 27(5): 741-56.

https://doi.org/10.1111/ene.14151

Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. Journal of Emergency Nursing 2000; 26(3): 216-22. https://doi.org/10.1016/S0099-1767(00)90093-X

Serdar CC, Cihan M, Yücel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochemia medica 2021; 31(1): 27-53. https://doi.org/10.11613/BM.2021.010502

Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. The American journal of medicine 2006; 119(10): 12-20. https://doi.org/10.1016/j.amjmed.2006.08.003

Hegendörfer E, Doukhopelnikoff A, Degryse J-M. Validity and reliability of the Multidimensional Dyspnoea Profile in older adults. ERJ Open Research 2021; 7(2).DOI: 10.1183/23120541.00606-2020

Flampouraris V, Kalinoglou S, Kandreviotou S, Raitsiou B, Kokolaki M, Tsiafaki X. Assessment of dyspnoea in Covid 19 patients using modified Borg scale. Signa Vitae 2021: S37-S. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1438981

Hassan SH, Beg FS, Sheikh SA. Usefulness of modified Borg scale for dyspnoea in chronic obstructive pulmonary diseases and asthma in a rural population of Karachi. Pakistan Journal of Chest Medicine 2007; 13(3). https://www.pjcm.net/index.php/pjcm/article/view/197

Ilgin D, Ozalevli S, Karaali HK, Cimrin AH, Ucan ES. Gender effect on the use of modified Borg and visual analog scales in the evaluation of dyspnea in chronic obstructive pulmonary disease. Pak J Med Sci 2010; 26: 76-81. https://pjms.com.pk/issues/janmar2010/pdf/article17.pdf

Downloads

Published

03/30/2024

How to Cite

Mehmood, A., Abbas, R., Saeed, A., Saleem, S. ., Nawaz, S. ., & Tabassum, S. (2024). Assessment of Dyspnea in Patients with Chronic Obstructive Lung Diseases with Modified Borg Scale; Descriptive Cross-Sectional Study: Assessment of Dyspnea in Chronic Obstructive Lung Diseases. The Healer Journal of Physiotherapy and Rehabilitation Sciences, 4(3), 998–1005. https://doi.org/10.55735/hjprs.v4i3.243

Issue

Section

Articles

Categories

Most read articles by the same author(s)